{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T07:48:03Z","timestamp":1779004083463,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,19]]},"DOI":"10.7759\/cureus.67215","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T17:08:11Z","timestamp":1724087291000},"source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and Prognostic Impact of Hyponatremia in Guillain-Barr\u00e9 Syndrome: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Yasemin","family":"Ekmekyapar F\u0131rat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep","family":"Karaoglu Ak\u0131nc\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Buse G\u00fcl","family":"Belen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cansu G\u00fclcihan","family":"T\u00fcrkok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevki","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibel","family":"Karsidag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes RA","year":"2005","unstructured":"Hughes RA, Cornblath DR. Guillain-Barr\u00e9 syndrome. Lancet. 2005, 366:1653-66. 10.1016\/S0140-6736(05)67665-9","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410440115","article-title":"Neuronal molecular mimicry in immune-mediated neurologic disease","volume":"44","author":"Levin MC","year":"1998","unstructured":"Levin MC, Krichavsky M, Berk J, et al.. Neuronal molecular mimicry in immune-mediated neurologic disease. Ann Neurol. 1998, 44:87-98. 10.1002\/ana.410440115","journal-title":"Ann Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410120202","article-title":"Neurological complications of immunization","volume":"12","author":"Fenichel GM","year":"1982","unstructured":"Fenichel GM. Neurological complications of immunization. Ann Neurol. 1982, 12:119-28. 10.1002\/ana.410120202","journal-title":"Ann Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31820d8b40","article-title":"Guillain-Barre syndrome and SIADH","volume":"76","author":"Saifudheen K","year":"2011","unstructured":"Saifudheen K, Jose J, Gafoor VA, Musthafa M. Guillain-Barre syndrome and SIADH. Neurology. 2011, 76:701-4. 10.1212\/WNL.0b013e31820d8b40","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-4598(199709)20:9<1102::aid-mus2>3.0.co;2-c","article-title":"Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations: assessments based on controlled treatment trials in patients with neurological diseases","volume":"20","author":"Koffman BM","year":"1997","unstructured":"Koffman BM, Dalakas MC. Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations: assessments based on controlled treatment trials in patients with neurological diseases. Muscle Nerve. 1997, 20:1102-7. 10.1002\/(sici)1097-4598(199709)20:9&lt;1102::aid-mus2&gt;3.0.co;2-c","journal-title":"Muscle Nerve"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2009.192369","article-title":"Renal salt wasting as part of dysautonomia in Guillain-Barre syndrome","volume":"82","author":"Lenhard T","year":"2011","unstructured":"Lenhard T, Grimm C, Ringleb PA. Renal salt wasting as part of dysautonomia in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 2011, 82:1051-3. 10.1136\/jnnp.2009.192369","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021, 10:89. 10.1186\/s13643-021-01626-4","journal-title":"Syst Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.24875\/rmn.22000081","article-title":"Guillain-Barre syndrome with hyponatremia, more than a simple finding","volume":"24","author":"Mart\u00ednez-Pi\u00f1a DA","year":"2023","unstructured":"Mart\u00ednez-Pi\u00f1a DA, Garc\u00eda-Hern\u00e1ndez JF, Vargas-Ca\u00f1as ES, Violante-Villanueva A, L\u00f3pez-Hern\u00e1ndez JC. Guillain-Barre syndrome with hyponatremia, more than a simple finding. Rev Mex Neurocien. 2023, 24:71-7. 10.24875\/rmn.22000081","journal-title":"Rev Mex Neurocien"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1445-5994.2002.00322.x","article-title":"Guillain-Barr\u00e9 syndrome and hyponatraemia","volume":"33","author":"Colls BM","year":"2003","unstructured":"Colls BM. Guillain-Barr\u00e9 syndrome and hyponatraemia. Intern Med J. 2003, 33:5-9. 10.1046\/j.1445-5994.2002.00322.x","journal-title":"Intern Med J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.729252","article-title":"Sodium levels predict disability at discharge in guillain-barr\u00e9 syndrome: a retrospective cohort study","volume":"12","author":"Gagliardi D","year":"2021","unstructured":"Gagliardi D, Faravelli I, Podest\u00e0 MA, et al.. Sodium levels predict disability at discharge in guillain-barr\u00e9 syndrome: a retrospective cohort study. Front Neurol. 2021, 12:729252. 10.3389\/fneur.2021.729252","journal-title":"Front Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12459","article-title":"Hyponatraemia in Guillain-Barr\u00e9 syndrome revisited","volume":"133","author":"Hiew FL","year":"2016","unstructured":"Hiew FL, Winer JB, Rajabally YA. Hyponatraemia in Guillain-Barr\u00e9 syndrome revisited. Acta Neurol Scand. 2016, 133:295-301. 10.1111\/ane.12459","journal-title":"Acta Neurol Scand"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1179\/1743132814Y.0000000455","article-title":"Hyponatremia is a predictor for poor outcome in Guillain-Barr\u00e9 syndrome","volume":"37","author":"Wang Y","year":"2015","unstructured":"Wang Y, Liu J. Hyponatremia is a predictor for poor outcome in Guillain-Barr\u00e9 syndrome. Neurol Res. 2015, 37:347-51. 10.1179\/1743132814Y.0000000455","journal-title":"Neurol Res"},{"key":"ref13","article-title":"Management and outcome of severe Guillain-Barr\u00e9 syndrome","volume":"88","author":"Ng KK","year":"1995","unstructured":"Ng KK, Howard RS, Fish DR, Hirsch NP, Wiles CM, Murray NM, Miller DH. Management and outcome of severe Guillain-Barr\u00e9 syndrome. QJM. 1995, 88:243-50.","journal-title":"QJM"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0000000000000157","article-title":"Hyponatremia in Guillain-Barr\u00e9 syndrome","volume":"18","author":"Rumalla K","year":"2017","unstructured":"Rumalla K, Reddy AY, Letchuman V, Mittal MK. Hyponatremia in Guillain-Barr\u00e9 syndrome. J Clin Neuromuscul Dis. 2017, 18:207-17. 10.1097\/CND.0000000000000157","journal-title":"J Clin Neuromuscul Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808273390914","article-title":"Intravenous immune globulin and pseudohyponatremia","volume":"339","author":"Lawn N","year":"1998","unstructured":"Lawn N, Wijdicks EF, Burritt MF. Intravenous immune globulin and pseudohyponatremia. N Engl J Med. 1998, 339:632. 10.1056\/NEJM199808273390914","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198005000-00004","article-title":"Urinary antidiuretic hormone excretion during mechanical ventilation and weaning in man","volume":"52","author":"Hemmer M","year":"1980","unstructured":"Hemmer M, Viquerat CE, Suter PM, Vallotton MB. Urinary antidiuretic hormone excretion during mechanical ventilation and weaning in man. Anesthesiology. 1980, 52:395-400. 10.1097\/00000542-198005000-00004","journal-title":"Anesthesiology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2017\/30445.10662","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone preceding Guillain-Barr\u00e9 syndrome","volume":"11","author":"James J","year":"2017","unstructured":"James J, Jose J. Syndrome of inappropriate secretion of antidiuretic hormone preceding Guillain-Barr\u00e9 syndrome. J Clin Diagn Res. 2017, 11:OD16-7. 10.7860\/JCDR\/2017\/30445.10662","journal-title":"J Clin Diagn Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/283830-prevalence-and-prognostic-impact-of-hyponatremia-in-guillain-barr-syndrome-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T17:08:16Z","timestamp":1724087296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/283830-prevalence-and-prognostic-impact-of-hyponatremia-in-guillain-barr-syndrome-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.67215","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,19]]}}}